Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

By Athyros Vasilios G.   Mikhailidis Dimitri P.   Papageorgiou Athanasios A.   Symeonidis Athanasios N.   Daskalopoulou Stella S.   Kakafika Anna I.   Pehlivanidis Anthimos N.   Bouloukos Vasilios I.   Langer Anatoly    

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1385-1392

Informa Healthcare

Access to resources Recommend Favorite

Imaging biomarkers to track subclinical atherosclerosis in heterozygous familial hypercholesterolemia

By Miname Marcio H   Santos Raul D  

Clinical Lipidology, Vol. 8, Iss. 2, 2013-04 ,pp. : 231-242

Future Medicine

Access to resources Recommend Favorite

A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study

By Farsang C.   Athyros V.   Gaw A.    

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1945-1956

Informa Healthcare

Access to resources Recommend Favorite

The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value – an Evaluation of Rosuvastatin therapY compared with atorvastatin

By Fonseca Francisco A. H.   Ruiz Alvaro   Cardona-Muñoz Ernesto G.   Silva Jose M.   Fuenmayor Nery   Marotti Marcelo  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1307-1316

Informa Healthcare

Access to resources Recommend Favorite

Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease

By Andican Gulnur   Seven Arzu   Uncu Murat   Cantasdemir Murat   Numan Furuzan   Burcak Gulden  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 6, 2008-10 ,pp. : 473-478

Informa Healthcare

Access to resources Recommend Favorite